Karin Jooss

Karin Jooss

Company: Gritstone Bio

Job title: Head of R&D


Industry Leader’s Fireside Chat 11:00 am

An executive panel discussion from the C-level leaders of the field to set the scene on neoantigen based therapy development.Read more

day: Day Two

Development of Shared Neoantigen Vaccines for Off-the-Shelf Cancer Therapy 4:00 pm

• Machine learning prediction of shared neoantigens combined with potent viral vector delivery platforms was applied to the development of a cancer vaccine for the treatment of patients with advanced stage solid tumors • Clinical and translational data from a Phase 1/2 trial will be presented with learnings applied from “bench to bedside and back…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.